Modig Berndt sold $80K of PHVS
Modig Berndt (Chief Executive Officer) sold 2,292 shares of Pharvaris N.V. (PHVS) at $34.97 on 2026-07-13 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The CEO’s open-market sale is disclosed with a stated pre-arranged 10b5-1 plan, which generally lowers the probability of a strong negative fundamental interpretation.
Market read
Traders may note the insider sale for sentiment monitoring, but there is no new business or financial datapoint in the text.
What to watch
The article does not disclose any concurrent operational updates, guidance changes, or clinical/regulatory milestones, so the trading signal is limited to sentiment.
Background
The article is an SEC Form 4 insider transaction disclosure for Pharvaris N.V. (PHVS).
Ticker impact
Pharvaris CEO Modig Berndt sold 2,292 shares in an open-market transaction on 2026-07-13 at $34.9714, per Form 4.
Likely minimal immediate price impact; any effect is more sentiment-driven than fundamental.
The filing specifies a Rule 10b5-1 pre-arranged plan and an open-market sale, which typically reduces interpretive weight versus discretionary selling.
Market effects
No sector read-through; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Insider sales can be driven by diversification or tax planning and may not reflect bearish expectations, especially under a 10b5-1 plan.
Key entities
- issuerPharvaris N.V.
Company whose CEO insider sale is disclosed on SEC Form 4.
- insiderModig Berndt
CEO and director who executed the reported sale.
- trading mechanismRule 10b5-1 plan
Pre-arranged plan cited as Yes, reducing discretionary-signal strength.
